(Circulation. 1995;92:15-23.)
© 1995 American Heart Association, Inc.
Articles |
Quantitative Measurements of Cardiac Phosphorus Metabolites in Coronary Artery Disease by 31P Magnetic Resonance Spectroscopy
From the First Department of Internal Medicine and the Molecular Neurobiology Research Center (T.I.), Shiga University of Medical Science, Otsu, Japan.
Background 31P metabolite measurements in the human heart by magnetic resonance spectroscopy (MRS) have been reported previously. By use of a method in which metabolite content was quantified with reference to a standard located outside the chest, it has become possible to measure the content of phosphocreatine (PCr) and ATP in vivo in the human heart. In this study, PCr and ATP contents were measured by 31P MRS and compared in human myocardium with reversible ischemia or scar diagnosed by exercise thallium scintigraphy.
Methods and Results Forty-one subjects with stenosis of the left anterior descending coronary artery (>50%) and 11 healthy control subjects (C) composed the present study group. Patients were divided into two groups on the basis of exercise 201Tl scintigraphy: a reversible 201Tl defect group (RD[+], n=29) who demonstrated redistribution at late image and a fixed 201Tl defect group (RD[-], n=12). While the subjects lay supine within the magnet, 31P MR spectra were obtained from the anterior and apical regions of the left ventricle by slice-selected one-dimensional chemical shift imaging. For metabolite quantification, a standard was placed at the center of the surface coil. ANOVA revealed significant differences among the three groups with respect to the mean (±SD) PCr at rest (C, 12.14±4.25 >RD[+], 7.64±3.00 >RD[-], 3.94±2.21 µmol/g wet heart tissue, P<.05) as well as a significant decrease in ATP in the RD(-) group (C, 7.72±2.97; RD[+], 6.35±3.17 >RD[-], 4.35±1.52 µmol/g wet heart tissue, P<.05).
Conclusions Compared with healthy control subjects, PCr content decreased significantly in patients with both reversible and fixed 201Tl defects, and ATP content decreased significantly in subjects with fixed thallium defects. These results suggest that the measurement of ATP content in the human heart by 31P MRS is a clinically important method for the evaluation of myocardial viability.
Key Words: magnetic resonance imaging • phosphates • myocardium • exercise • thallium
This article has been cited by other articles:
 |
|
 |
|
  T. T. Phan, G. N. Shivu, A. Choudhury, K. Abozguia, C. Davies, U. Naidoo, I. Ahmed, Z. Yousef, J. Horowitz, and M. Frenneaux Multi-centre experience on the use of perhexiline in chronic heart failure and refractory angina: old drug, new hope Eur J Heart Fail, September 1, 2009; 11(9): 881 - 886. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Gupta, V. P. Chacko, and R. G. Weiss Abnormal energetics and ATP depletion in pressure-overload mouse hearts: in vivo high-energy phosphate concentration measures by noninvasive magnetic resonance Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H59 - H64. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Bottomley, K. C. Wu, G. Gerstenblith, S. P. Schulman, A. Steinberg, and R. G. Weiss Reduced Myocardial Creatine Kinase Flux in Human Myocardial Infarction: An In Vivo Phosphorus Magnetic Resonance Spectroscopy Study Circulation, April 14, 2009; 119(14): 1918 - 1924. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Hudsmith and S. Neubauer Magnetic resonance spectroscopy in myocardial disease. J. Am. Coll. Cardiol. Img., January 1, 2009; 2(1): 87 - 96. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. S. Smith, P. A. Bottomley, S. P. Schulman, G. Gerstenblith, and R. G. Weiss Altered Creatine Kinase Adenosine Triphosphate Kinetics in Failing Hypertrophied Human Myocardium Circulation, September 12, 2006; 114(11): 1151 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Fragasso, G. Perseghin, F. De Cobelli, A. Esposito, A. Palloshi, G. Lattuada, P. Scifo, G. Calori, A. Del Maschio, and A. Margonato Effects of metabolic modulation by trimetazidine on left ventricular function and phosphocreatine/adenosine triphosphate ratio in patients with heart failure Eur. Heart J., April 2, 2006; 27(8): 942 - 948. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. C. Chen and O. Ogut Decline of contractility during ischemia-reperfusion injury: actin glutathionylation and its effect on allosteric interaction with tropomyosin Am J Physiol Cell Physiol, March 1, 2006; 290(3): C719 - C727. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. V. Naumova, V. P. Chacko, R. Ouwerkerk, L. Stull, E. Marban, and R. G. Weiss Xanthine oxidase inhibitors improve energetics and function after infarction in failing mouse hearts Am J Physiol Heart Circ Physiol, February 1, 2006; 290(2): H837 - H843. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Caus, F. Kober, P. Marin, A. Mouly-Bandini, J. Quilici, D. Metras, P. J. Cozzone, and M. Bernard Non-invasive diagnostic of cardiac allograft vasculopathy by 31P magnetic resonance chemical shift imaging Eur. J. Cardiothorac. Surg., January 1, 2006; 29(1): 45 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Weiss, G. Gerstenblith, and P. A. Bottomley ATP flux through creatine kinase in the normal, stressed, and failing human heart PNAS, January 18, 2005; 102(3): 808 - 813. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Pennell, U. P. Sechtem, C. B. Higgins, W. J. Manning, G. M. Pohost, F. E. Rademakers, A. C. van Rossum, L. J. Shaw, and E. K. Yucel Clinical indications for cardiovascular magnetic resonance (CMR): Consensus Panel report Eur. Heart J., November 1, 2004; 25(21): 1940 - 1965. [Full Text] [PDF]
|
|
|
|
 |
|
 K. C. Wu and J. A.C. Lima Noninvasive Imaging of Myocardial Viability: Current Techniques and Future Developments Circ. Res., December 12, 2003; 93(12): 1146 - 1158. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Nahrendorf, K.-H. Hiller, A. Greiser, S. Kohler, T. Neuberger, K. Hu, C. Waller, M. Albrecht, S. Neubauer, A. Haase, et al. Chronic coronary artery stenosis induces impaired function of remote myocardium: MRI and spectroscopy study in rat Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2712 - H2721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Ogut and F. V. Brozovich Creatine Phosphate Consumption and the Actomyosin Crossbridge Cycle in Cardiac Muscles Circ. Res., July 11, 2003; 93(1): 54 - 60. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Beer, T. Seyfarth, J.o. Sandstede, W. Landschutz, C. Lipke, H. Kostler, M. von Kienlin, K. Harre, D. Hahn, and S. Neubauer Absolute concentrations of high-energy phosphate metabolites in normal, hypertrophied, and failing human myocardium measured noninvasively with 31P-SLOOP magnetic resonance spectroscopy J. Am. Coll. Cardiol., October 2, 2002; 40(7): 1267 - 1274. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Mahrholdt, A. Wagner, R.M. Judd, and U. Sechtem Assessment of myocardial viability by cardiovascular magnetic resonance imaging Eur. Heart J., April 2, 2002; 23(8): 602 - 619. [Full Text] [PDF]
|
|
|
|
 |
|
 P. A. Bottomley and R. G. Weiss Noninvasive Localized MR Quantification of Creatine Kinase Metabolites in Normal and Infarcted Canine Myocardium Radiology, May 1, 2001; 219(2): 411 - 418. [Abstract] [Full Text]
|
|
|
|
|
|
H. Wiggers, M. Noreng, P. K. Paulsen, M. Bottcher, H. Egeblad, T. T. Nielsen, and H. E. Botker Energy stores and metabolites in chronic reversibly and irreversibly dysfunctional myocardium in humans J. Am. Coll. Cardiol., January 1, 2001; 37(1): 100 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Neubauer, M. Horn, M. Cramer, K. Harre, J. B. Newell, W. Peters, T. Pabst, G. Ertl, D. Hahn, J. S. Ingwall, et al. Myocardial Phosphocreatine-to-ATP Ratio Is a Predictor of Mortality in Patients With Dilated Cardiomyopathy Circulation, October 7, 1997; 96(7): 2190 - 2196. [Abstract] [Full Text]
|
|
|
|
|
|
G. M. Pohost Is 31P-NMR Spectroscopic Imaging a Viable Approach to Assess Myocardial Viability? Circulation, July 1, 1995; 92(1): 9 - 10. [Full Text]
|
|